"Aiosyn...has announced the latest advancement in their automated quality control (QC) algorithm. Aiosyn’s QC solution, AiosynQC, is now fully compatible with immunohistochemistry (IHC) slides, in addition to hematoxylin and eosin (H&E) slides. This update extends the benefits of AiosynQC and allows laboratories that rely significantly on IHC staining to further streamline operations."
"Aiosyn...has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to accelerate the development of AI technology for breast and skin cancer diagnostics. With the AIRAT project, the three organizations will join forces to introduce CE-marked deep learning algorithms for automated mitosis detection to the market."
"Aiosyn...has announced the integration of its AI-powered automated quality control (QC) algorithm in the Sectra Amplifier Marketplace. Through the Sectra platform, pathology laboratories can now easily access and integrate AiosynQC into their workflow."